Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
RYAN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
seekingalpha.com
3 hours ago
prnewswire.com
16 hours ago
businesswire.com
16 hours ago
prnewswire.com
16 hours ago
fool.com
17 hours ago
zacks.com
18 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
+28%
0.32
vs 0.25
Q4.23
+30%
0.35
vs 0.27
Q1.24
+35%
0.35
vs 0.26
Q2.24
+29%
0.58
vs 0.45
Q3.24
+28%
0.41
vs 0.32
Q4.24
+29%
0.45
vs 0.35
Q1.25
+11%
0.39
vs 0.35
Q2.25
+14%
0.66
vs 0.58
Q3.25
+16%
0.48
vs 0.41
Q4.25
+18%
0.53
vs 0.45
Sales Growth
YoY
Current
Estimates
Q3.23
+22%
501.9M vs 412M
Q4.23
+28%
555.8M vs 435M
Q1.24
+22%
558.6M vs 457.6M
Q2.24
+20%
701.9M vs 585.1M
Q3.24
+20%
604.7M vs 501.9M
Q4.24
+19%
663.5M vs 555.8M
Q1.25
+24%
690.2M vs 558.6M
Q2.25
+22%
855.2M vs 701.9M
Q3.25
+23%
741.1M vs 604.7M
Q4.25
+19%
787.7M vs 663.5M
Return on Equity
QoQ
Q1.23
+7%
0.07
vs 0.1
Q2.23
+5%
0.05
vs 0.07
Q3.23
-1%
-0.01
vs 0.05
Q4.23
+4%
0.04
vs -0.01
Q1.24
+3%
0.03
vs 0.04
Q2.24
+8%
0.08
vs 0.03
Q3.24
+3%
0.03
vs 0.08
Q4.24
+2%
0.02
vs 0.03
Q1.25
-5%
-0.05
vs 0.02
Q2.25
+9%
0.09
vs -0.05
Institutionnal Ownership
QoQ
Q1.23
203
203
vs 195
4%
Q2.23
218
218
vs 203
7%
Q3.23
249
249
vs 218
14%
Q4.23
262
262
vs 249
5%
Q1.24
274
274
vs 262
5%
Q2.24
307
307
vs 274
12%
Q3.24
354
354
vs 307
15%
Q4.24
368
368
vs 354
4%
Q1.25
378
378
vs 368
3%
Q2.25
370
370
vs 378
-2%
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
61.00(1.96%)
Number of analyst
1
Last analyst upgrade/downgrade
Cantor Fitzgerald
initialisePrevious: Not converted
2025-08-12
Now: Neutral
BMO Capital
upgradePrevious: Not converted
2024-09-24
Now: Outperform
Barclays
initialisePrevious: Not converted
2024-09-04
Now: Overweight
Wells Fargo
downgradePrevious: Overweight
2024-07-11
Now: Equal-Weight
Quote Panel
Key Metrics
Relative Strength
RYAN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|